Form 8-K - Current report:
SEC Accession No. 0001628280-16-010596
Filing Date
2016-02-01
Accepted
2016-01-29 17:35:39
Documents
1
Period of Report
2016-01-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K MBONNERCFOAPPOINTMENT a8k-michaelbonnerxcfoappoi.htm 8-K 21805
  Complete submission text file 0001628280-16-010596.txt   22942
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 161374639
SIC: 2834 Pharmaceutical Preparations